The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Levosulpiride Market Research Report 2025
Synopsis
Levosulpiride is a substituted benzamide antipsychotic.
The global Levosulpiride market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Levosulpiride is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Levosulpiride is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Levosulpiride include Sun Pharmaceutical Industries, Vasoya Industries, Bona Chemical, New Donghai Pharmaceutical, Suzhou Chenghe Pharmaceutical & Chemical and Harbin Gloria Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Levosulpiride, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Levosulpiride.
Report Scope
The Levosulpiride market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Levosulpiride market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Levosulpiride manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sun Pharmaceutical Industries
Vasoya Industries
Bona Chemical
New Donghai Pharmaceutical
Suzhou Chenghe Pharmaceutical & Chemical
Harbin Gloria Pharmaceuticals
Segment by Type
Above 98%
Below 98%
Segment by Application
Tablet
Capsule
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Levosulpiride manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Levosulpiride in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Levosulpiride is a substituted benzamide antipsychotic.
The global Levosulpiride market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Levosulpiride is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Levosulpiride is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Levosulpiride include Sun Pharmaceutical Industries, Vasoya Industries, Bona Chemical, New Donghai Pharmaceutical, Suzhou Chenghe Pharmaceutical & Chemical and Harbin Gloria Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Levosulpiride, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Levosulpiride.
Report Scope
The Levosulpiride market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Levosulpiride market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Levosulpiride manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sun Pharmaceutical Industries
Vasoya Industries
Bona Chemical
New Donghai Pharmaceutical
Suzhou Chenghe Pharmaceutical & Chemical
Harbin Gloria Pharmaceuticals
Segment by Type
Above 98%
Below 98%
Segment by Application
Tablet
Capsule
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Levosulpiride manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Levosulpiride in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Levosulpiride Market Overview
1.1 Product Overview and Scope of Levosulpiride
1.2 Levosulpiride Segment by Type
1.2.1 Global Levosulpiride Market Value Comparison by Type (2024-2030)
1.2.2 Above 98%
1.2.3 Below 98%
1.3 Levosulpiride Segment by Application
1.3.1 Global Levosulpiride Market Value by Application: (2024-2030)
1.3.2 Tablet
1.3.3 Capsule
1.3.4 Other
1.4 Global Levosulpiride Market Size Estimates and Forecasts
1.4.1 Global Levosulpiride Revenue 2019-2030
1.4.2 Global Levosulpiride Sales 2019-2030
1.4.3 Global Levosulpiride Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Levosulpiride Market Competition by Manufacturers
2.1 Global Levosulpiride Sales Market Share by Manufacturers (2019-2024)
2.2 Global Levosulpiride Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Levosulpiride Average Price by Manufacturers (2019-2024)
2.4 Global Levosulpiride Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Levosulpiride, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Levosulpiride, Product Type & Application
2.7 Levosulpiride Market Competitive Situation and Trends
2.7.1 Levosulpiride Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Levosulpiride Players Market Share by Revenue
2.7.3 Global Levosulpiride Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Levosulpiride Retrospective Market Scenario by Region
3.1 Global Levosulpiride Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Levosulpiride Global Levosulpiride Sales by Region: 2019-2030
3.2.1 Global Levosulpiride Sales by Region: 2019-2024
3.2.2 Global Levosulpiride Sales by Region: 2025-2030
3.3 Global Levosulpiride Global Levosulpiride Revenue by Region: 2019-2030
3.3.1 Global Levosulpiride Revenue by Region: 2019-2024
3.3.2 Global Levosulpiride Revenue by Region: 2025-2030
3.4 North America Levosulpiride Market Facts & Figures by Country
3.4.1 North America Levosulpiride Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Levosulpiride Sales by Country (2019-2030)
3.4.3 North America Levosulpiride Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Levosulpiride Market Facts & Figures by Country
3.5.1 Europe Levosulpiride Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Levosulpiride Sales by Country (2019-2030)
3.5.3 Europe Levosulpiride Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Levosulpiride Market Facts & Figures by Country
3.6.1 Asia Pacific Levosulpiride Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Levosulpiride Sales by Country (2019-2030)
3.6.3 Asia Pacific Levosulpiride Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Levosulpiride Market Facts & Figures by Country
3.7.1 Latin America Levosulpiride Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Levosulpiride Sales by Country (2019-2030)
3.7.3 Latin America Levosulpiride Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Levosulpiride Market Facts & Figures by Country
3.8.1 Middle East and Africa Levosulpiride Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Levosulpiride Sales by Country (2019-2030)
3.8.3 Middle East and Africa Levosulpiride Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Levosulpiride Sales by Type (2019-2030)
4.1.1 Global Levosulpiride Sales by Type (2019-2024)
4.1.2 Global Levosulpiride Sales by Type (2025-2030)
4.1.3 Global Levosulpiride Sales Market Share by Type (2019-2030)
4.2 Global Levosulpiride Revenue by Type (2019-2030)
4.2.1 Global Levosulpiride Revenue by Type (2019-2024)
4.2.2 Global Levosulpiride Revenue by Type (2025-2030)
4.2.3 Global Levosulpiride Revenue Market Share by Type (2019-2030)
4.3 Global Levosulpiride Price by Type (2019-2030)
5 Segment by Application
5.1 Global Levosulpiride Sales by Application (2019-2030)
5.1.1 Global Levosulpiride Sales by Application (2019-2024)
5.1.2 Global Levosulpiride Sales by Application (2025-2030)
5.1.3 Global Levosulpiride Sales Market Share by Application (2019-2030)
5.2 Global Levosulpiride Revenue by Application (2019-2030)
5.2.1 Global Levosulpiride Revenue by Application (2019-2024)
5.2.2 Global Levosulpiride Revenue by Application (2025-2030)
5.2.3 Global Levosulpiride Revenue Market Share by Application (2019-2030)
5.3 Global Levosulpiride Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sun Pharmaceutical Industries
6.1.1 Sun Pharmaceutical Industries Corporation Information
6.1.2 Sun Pharmaceutical Industries Description and Business Overview
6.1.3 Sun Pharmaceutical Industries Levosulpiride Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sun Pharmaceutical Industries Levosulpiride Product Portfolio
6.1.5 Sun Pharmaceutical Industries Recent Developments/Updates
6.2 Vasoya Industries
6.2.1 Vasoya Industries Corporation Information
6.2.2 Vasoya Industries Description and Business Overview
6.2.3 Vasoya Industries Levosulpiride Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Vasoya Industries Levosulpiride Product Portfolio
6.2.5 Vasoya Industries Recent Developments/Updates
6.3 Bona Chemical
6.3.1 Bona Chemical Corporation Information
6.3.2 Bona Chemical Description and Business Overview
6.3.3 Bona Chemical Levosulpiride Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bona Chemical Levosulpiride Product Portfolio
6.3.5 Bona Chemical Recent Developments/Updates
6.4 New Donghai Pharmaceutical
6.4.1 New Donghai Pharmaceutical Corporation Information
6.4.2 New Donghai Pharmaceutical Description and Business Overview
6.4.3 New Donghai Pharmaceutical Levosulpiride Sales, Revenue and Gross Margin (2019-2024)
6.4.4 New Donghai Pharmaceutical Levosulpiride Product Portfolio
6.4.5 New Donghai Pharmaceutical Recent Developments/Updates
6.5 Suzhou Chenghe Pharmaceutical & Chemical
6.5.1 Suzhou Chenghe Pharmaceutical & Chemical Corporation Information
6.5.2 Suzhou Chenghe Pharmaceutical & Chemical Description and Business Overview
6.5.3 Suzhou Chenghe Pharmaceutical & Chemical Levosulpiride Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Suzhou Chenghe Pharmaceutical & Chemical Levosulpiride Product Portfolio
6.5.5 Suzhou Chenghe Pharmaceutical & Chemical Recent Developments/Updates
6.6 Harbin Gloria Pharmaceuticals
6.6.1 Harbin Gloria Pharmaceuticals Corporation Information
6.6.2 Harbin Gloria Pharmaceuticals Description and Business Overview
6.6.3 Harbin Gloria Pharmaceuticals Levosulpiride Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Harbin Gloria Pharmaceuticals Levosulpiride Product Portfolio
6.6.5 Harbin Gloria Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Levosulpiride Industry Chain Analysis
7.2 Levosulpiride Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Levosulpiride Production Mode & Process
7.4 Levosulpiride Sales and Marketing
7.4.1 Levosulpiride Sales Channels
7.4.2 Levosulpiride Distributors
7.5 Levosulpiride Customers
8 Levosulpiride Market Dynamics
8.1 Levosulpiride Industry Trends
8.2 Levosulpiride Market Drivers
8.3 Levosulpiride Market Challenges
8.4 Levosulpiride Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
